# Etoposide

NDC: 68001-265
Generic name: Etoposide
Labeler / Manufacturer: BluePoint Laboratories
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20131114

FDA application: ANDA074513

## Active ingredients

- ETOPOSIDE: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68001-265"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68001-265
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=157d4e0f-806d-4011-9dec-97e2449e507b